IDT Biologika sets up in the US
This article was originally published in Scrip
The German contract biologics manufacturer, IDT Biologika, is establishing an office and corporation in the US, led by executive vice-president Peter Linzmeyer, to expand its business in the country. It is located in Herndon, Virginia, just outside Washington, DC.
You may also be interested in...
Switzerland’s Polyphor has redefined its business strategy and is aiming to become a leaner organization, with a potential first-in-class immuno-oncologic, balixafortide, in late-stage clinical development for breast cancer.
Germany’s family-controlled big pharma, Merck KGaA, is divesting its allergens business, Allergopharma to the fast-growing Munich healthcare company, Dermapharm Holding.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.